Microsoft Office 2021 ProPlus Online Installer 3.2.2 free downloads

Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC Priority to US13/368,812 priority Critical patent/US8841330B2/en Publication of US20120142742A1 publication Critical patent/US20120142742A1/en Priority to US14/333,533 priority patent/US20140329866A1/en Application granted granted Critical Publication of US8841330B2 publication Critical patent/US8841330B2/en Anticipated expiration legal-status Critical Status Expired - Fee Related legal-status Critical Current Links US case filed in Delaware District Court litigation Source: District Court Jurisdiction: Delaware District Court 'Unified Patents Litigation Data' by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation First worldwide family litigation filed litigation Critical (B2) 'Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Bayer Healthcare LLC Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Wood Current Assignee (The listed assignees may be inaccurate.

( en Inventor Bernd Riedl Jacques Dumas Uday Khire Timothy B. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Fee Related Application number US13/368,812 Other versions US20120142742A1 Google Patents Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsĭownload PDF Info Publication number US8841330B2 US8841330B2 US13/368,812 US201213368812A US8841330B2 US 8841330 B2 US8841330 B2 US 8841330B2 US 201213368812 A US201213368812 A US 201213368812A US 8841330 B2 US8841330 B2 US 8841330B2 Authority US United States Prior art keywords trifluoromethyl aniline chloro etoac urea Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US8841330B2 - Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

US8841330B2 - Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Microsoft Office 2021 ProPlus Online Installer 3.2.2 free downloads